Olopatadine Rafarm (Olopatadine)

Olopatadine Rafram is an antihistamine that acts on ocular allergic reactions.

• Allergic conjunctivitis: Reduces eye redness, itching, and swelling.
• Seasonal allergic eye disease: Alleviates symptoms triggered by pollen and seasonal allergens.
• Vernal keratoconjunctivitis: Provides relief from chronic itching and photophobia.
• Contact lens‑related irritation: Helps control mild allergic responses in contact lens wearers.
• Post‑operative ocular inflammation: Supports comfort after eye surgery.
• Ocular pruritus caused by environmental irritants : Offers symptomatic relief.

• Olopatadine is a selective antagonist of the histamine H1 receptor and a mast‑cell stabilizer. By blocking H1 receptors, it prevents histamine‑mediated vasodilation and nerve stimulation that cause itching and redness. Its mast‑cell stabilizing action inhibits the release of inflammatory mediators such as histamine, leukotrienes, and prostaglandins, reducing ocular inflammation and allergic symptoms.

Olopatadine Rafram may cause a range of ocular and systemic reactions.

Common Side Effects

• Burning sensation: Mild transient burning upon instillation.
• Stinging or discomfort: Temporary irritation after dosing.
• Blurred vision: Short‑term visual haziness that resolves quickly.
• Redness of the eye: Mild conjunctival hyperemia.
• Tearing: Increased lacrimation.
• Foreign‑body sensation: Feeling of grit or sand.

Serious or Rare Side Effects

• Severe allergic reaction: Anaphylaxis or angio‑edema requiring emergency care.
• Persistent ocular pain: Ongoing discomfort beyond the initial administration period.
• Corneal ulceration: Rare ulcer formation on the cornea.
• Vision loss: Sudden decrease in visual acuity.
• Intra‑ocular pressure rise: Uncommon increase in eye pressure.
• Contact lens intolerance: Inability to wear lenses due to irritation.

When using Olopatadine Rafram, consider the following safety measures:

• Avoid self‑medication: Consult a healthcare professional before initiating therapy.
• Monitor for hypersensitivity: Discontinue if signs of rash or swelling appear.
• Use with caution in children: Safety data are limited for patients under 12 years.
• Contact lens wearers: Remove lenses before instillation and wait before reinserting.
• Pregnancy and lactation: Discuss the risk‑benefit of the treatment with the prescriber.
• Store at ambient temperature: Keep the bottle below 25 °C, in the original pack and protect from light.

• Olopatadine Rafram may interact with other ophthalmic or systemic agents.
• Major Interactions (Avoid):\n- Concomitant use ​        ​  ​   ​  ​  ​  ​   ​   ​     ​   ​   ​   ​  ​  ​-               ​   ​
• -     
• Moderate  
• -